Navigation Links
Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
Date:4/7/2013

SAN FRANCISCO, April 7, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research (AACR) Annual Meeting. NKTR-214 is a new immunocytokine that is being developed as a potential treatment for multiple cancers.  NKTR-214 targets the IL-2 receptor complex through selective receptor binding to the IL2Rβ subtype.  Activation of the IL2Rβ subtype promotes tumor killing by the body's own immune system.

"We are extremely encouraged by the dramatic efficacy observed with NKTR-214 treatment in an aggressive and resistant preclinical model of melanoma," said Stephen Doberstein , Ph.D., Senior Vice President and Chief Scientific Officer of Nektar Therapeutics.  "NKTR-214 is specifically designed to harness the potent immunostimulatory effects of the IL-2 receptor complex while minimizing the immunosuppressive effects that have greatly limited the efficacy of the native IL-2 protein.  Importantly, NKTR-214 represents the first application of our technology platform to target a receptor subtype in the tumor microenvironment while avoiding the unwanted effects from off-target receptor binding.  NKTR-214 also has improved pharmacokinetics and enhanced tumor penetration which allow for a ten-fold reduction in overall dosing.  We are excited about the potential of NKTR-214 to emerge as a powerful new immunotherapy in the fight against cancer."

NKTR-214 is a novel immunocytokine therapy that is engineered using Nektar's polymer conjugate technology to selectively target the beneficial IL-2 receptor complex.  In the preclinical data presented at AACR, NKTR-214 exhibits differentiated IL-2 receptor binding which res
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
2. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
3. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
4. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
5. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
6. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
8. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
9. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
10. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
11. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015 Woodford Patient ... Wellcome Trust and the Bill & Melinda Gates ... Kymab, a leading monoclonal antibody biopharmaceutical company, announced ... US$50 million to complete a US$90 million Series ... by Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") and ...
(Date:5/5/2015)... , LONDON and NEW YORK ... on ASEAN respiratory devices with a detailed analysis of:   ... diagnostic   - Markets such as Indonesia ... Philippines , Singapore , Thailand ... Australia , New Zealand and ...
(Date:5/5/2015)... -- CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused ... of infectious diseases, announced that it will report first ... Milby , Chief Executive Officer of CorMedix, will host ... 9:00 a.m. EDT.  In order to ... 1-201-689-8031 (outside the U.S.). All participants who dial in ...
Breaking Medicine Technology:Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 2Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 3Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 4Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 5CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2
(Date:5/6/2015)... May 06, 2015 ProTrailer Cartoon Volume ... self-animating generators for Final Cut Pro X . ... titles to a Final Cut Pro X project.It includes ... quality openers to any shot has never been easier. ... in mind, saving users time while adding amazing openers ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Healthcare marketing ... award and a silver award in the 2015 Aster ... care campaign and Ellis Medicine’s maternity campaign, respectively. The ... by healthcare organizations and marketing agencies. , The ... the service line — other/misc. category and hospital 150-200 ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The SGNY ... New York City, announced today that it was named ... for a presentation video produced on behalf of Intarcia ... the category of motion graphics. , The competition sponsored ... received over 6000 entries from 22 countries. The ...
(Date:5/6/2015)... May 06, 2015 The beverage industry ... drinks. Little Miracles organic tea and superfruit fusions stands ... ginseng and sweetened with agave, these delicious juice blends ... that seeks healthier ways to hydrate. , In collaboration ... invites people to raise a bottle of Lemongrass Tea ...
(Date:5/5/2015)... Aliso Viejo, CA (PRWEB) May 05, 2015 ... Studios , editors can quickly and easily add washed color ... contains a mathematical formula for modifying an image. The LUT ... the table. This pack comes with 90 washed CUBE LUT ... photography, FCPX LUT Monochromatic can give any footage a washed ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:Smith & Jones Wins in 2015 Aster Awards for Healthcare Marketing 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2
... the day. As many as 60 million more people around ... if the current prevention programmes are not expanded, experts have ... Jennifer Kates, vice president and director of HIV policy at ... reality is that HIV prevention groups have the tools, but ...
... researchers suggests that proteins that cause mad cow disease ... ,In laboratory tests, the researchers observed that high ... accumulation of beta amyloid, the building blocks of Alzheimer's ... says that the findings, published in the Proceedings of ...
... are meeting in Bangkok from Saturday to move forward the ... the Conference of the Parties to the WHO Framework Convention ... will take place from June 30 to July 6 2007 ... ,Outcomes of the meeting will help countries to strengthen ...
... to help people quit smoking? Get a national TV network ... of a new study that found calls to a national ... anchor Peter Jennings death from lung cancer. ,Its ... also have to advertise it, said Erik Augustson, a behavioral ...
... list Taj Mahal in the new Seven Wonders of the ... dust and smog. ,,Environmentalists and historians, worried that ... Taj Mahal black, have raised an alarm for saving the ... the Taj needs corrective treatment fast."We have to take measures, ...
... Bayer HealthCare Pharmaceuticals Inc. (NYSE: BAY) and Onyx Pharmaceuticals, ... Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets has ... (FDA) for the treatment of patients with hepatocellular carcinoma ... ,Nexavar is currently approved in more than 50 ...
Cached Medicine News:Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 2Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 3Health News:Proteins Behind Mad Cow Disease may Protect Against Alzheimer's 2Health News:WHO to Call for More Progress on Tobacco Control at Bangkok Moot 2Health News:National TV Promotion Triples Calls to Smoking Cessation Hotline 2Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2
The Shandon Cryotome Manual Cryostat features unique formalin fumigation, ergonomic design and automatic defrost. The microtome is located outside the cryochamber for easy cleaning....
... Specimen Processing System is used for tissue ... routine special stains where heat would accelerate ... during immunohistochemistry staining. , Product Detail ... to meet the growing workload demands. This ...
... a service that directly connects the ... customers laboratory to the Thermo Electron ... and Runcorn, U.K.* By using a ... site, high-value support services are made ...
... Shandon Excelsior Tissue Processor is ... using traditional reagents today. It ... outstanding features to provide benefits ... increased productivity, reagent cost savings ...
Medicine Products: